Alaunos Therapeutics Analyst Ratings
Alaunos Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a downgraded with a price target of $0.00 to $0.00. The current price Alaunos Therapeutics (TCRT) is trading at is $0.14, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | — | Laidlaw & Co. | Downgrades | Buy → Hold | |
| 05/15/2023 | 934.48% | HC Wainwright & Co. | → $1.5 | Upgrades | Neutral → Buy |
| 03/27/2023 | 1968.97% | Wells Fargo | → $3 | Assumes | → Overweight |
| 10/04/2022 | 1968.97% | Wells Fargo | → $3 | Assumes | → Overweight |
| 07/15/2022 | 1968.97% | Cantor Fitzgerald | → $3 | Assumes | → Overweight |
| 05/04/2022 | 1968.97% | Wells Fargo | → $3 | Upgrades | Equal-Weight → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/15/2023 | — | Laidlaw & Co. | 降級 | 買入 → 持有 | |
| 05/15/2023 | 934.48% | HC Wainwright & Co. | → 1.5 美元 | 升級 | 中性 → 買入 |
| 03/27/2023 | 1968.97% | 富國銀行 | → 3 美元 | 假設 | → 超重 |
| 2022 年 4 月 10 日 | 1968.97% | 富國銀行 | → 3 美元 | 假設 | → 超重 |
| 07/15/2022 | 1968.97% | 坎託·菲茨傑拉德 | → 3 美元 | 假設 | → 超重 |
| 05/04/2022 | 1968.97% | 富國銀行 | → 3 美元 | 升級 | 重量相等 → 超重 |
What is the target price for Alaunos Therapeutics (TCRT)?
Alaunos Therapeutics（TCRT）的目標價格是多少？
The latest price target for Alaunos Therapeutics (NASDAQ: TCRT) was reported by Laidlaw & Co. on August 15, 2023. The analyst firm set a price target for $0.00 expecting TCRT to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
Laidlaw & Co. 於2023年8月15日公佈了Alaunos Therapeutics（納斯達克股票代碼：TCRT）的最新目標股價。這家分析公司將目標股價定爲0.00美元，預計TCRT將在12個月內跌至-100.00％（可能下跌-100.00％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Alaunos Therapeutics (TCRT)?
分析師對Alaunos Therapeutics（TCRT）的最新評級是多少？
The latest analyst rating for Alaunos Therapeutics (NASDAQ: TCRT) was provided by Laidlaw & Co., and Alaunos Therapeutics downgraded their hold rating.
Alaunos Therapeutics（納斯達克股票代碼：TCRT）的最新分析師評級由Laidlaw & Co. 提供，Alaunos Therapeutics下調了持倉評級。
When is the next analyst rating going to be posted or updated for Alaunos Therapeutics (TCRT)?
Alaunos Therapeutics（TCRT）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alaunos Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alaunos Therapeutics was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析師在進行了廣泛的研究，包括瀏覽公開財務報表、與Alaunos Therapeutics的高管和客戶交談以及聽取業績電話會議後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Alaunos Therapeutics的最後一次評級是在2023年8月15日提交的，因此你應該預計下一個評級將在2024年8月15日左右公佈。
Is the Analyst Rating Alaunos Therapeutics (TCRT) correct?
分析師對 Alaunos Therapeutics (TCRT) 的評級正確嗎？
While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a downgraded with a price target of $0.00 to $0.00. The current price Alaunos Therapeutics (TCRT) is trading at is $0.14, which is out of the analyst's predicted range.
儘管評級是主觀的，會發生變化，但最新的Alaunos Therapeutics（TCRT）評級被下調，目標股價爲0.00美元至0.00美元。Alaunos Therapeutics（TCRT）目前的交易價格爲0.14美元，超出了分析師的預測區間。
